Mass mask-wearing notably reduces COVID-19 transmission - Leech, Gavin; Rogers-Smith, Charlie; Sandbrink, Jonas B.; Snodin, Benedict; Zinkov, Robert; Rader, Benjamin; Brownstein, John S.; Gal, Yarin; Bhatt, Samir; Sharma, Mrinank; Mindermann, Sören; Brauner, Jan M.; et al. (medRxiv, 2021)
Mask-wearing has been a controversial measure to control the COVID-19 pandemic. While masks are known to substantially reduce disease transmission in healthcare settings [1–3], studies in community settings report inconsistent results [4–6].Investigating the inconsistency within epidemiological studies, we find that a commonly used proxy, government mask mandates, does not correlate with large increases in mask-wearing in our window of analysis. We thus analyse the effect of mask-wearing on transmission instead, drawing on several datasets covering 92 regions on 6 continents, including the largest survey of individual-level wearing behaviour (n=20 million) [7]. Using a hierarchical Bayesian model, we estimate the effect of both mask-wearing and mask-mandates on transmission by linking wearing levels (or mandates) to reported cases in each region, adjusting for mobility and non-pharmaceutical interventions.We assess the robustness of our results in 123 experiments spanning 22 sensitivity analyses. Across these analyses, we find that an entire population wearing masks in public leads to a median reduction in the reproduction number R of 25.8%, with 95% of the medians between 22.2% and 30.9%. In our window of analysis, the median reduction in R associated with the wearing level observed in each region was 20.4% [2.0%, 23.3%]1. We do not find evidence that mandating mask-wearing reduces transmission. Our results suggest that mask-wearing is strongly affected by factors other than mandates.We establish the effectiveness of mass mask-wearing, and highlight that wearing data, not mandate data, are necessary to infer this effect.Competing Interest StatementThe authors have declared no competing interest.Funding StatementG. Leech was supported by the UKRI Centre for Doctoral Training in Interactive Artificial Intelligence (EP/S022937/1). C. Rogers-Smith was supported by a grant from Open Philanthropy. M. Sharma was supported by the EPSRC Centre for Doctoral Training in Autonomous Intelligent Machines and Systems (EP/S024050/1) and a grant from the EA Funds programme. S. Mindermann’s funding for graduate studies was from Oxford University and DeepMind. S. Bhatt acknowledges funding from the MRC Centre for Global Infectious Disease Analysis (MR/R015600/1), jointly funded by the U.K. Medical Research Council (MRC) and the U.K. Foreign, Commonwealth and Development Office (FCDO), under the MRC/FCDO Concordat agreement; part of the EDCTP2 program supported by the European Union; and acknowledges funding by Community Jameel; UKRI (MR/V038109/1), the Academy of Medical Sciences Springboard Award (SBF004/1080), the MRC (MR/R015600/1), the BMGF (OPP1197730), Imperial College Healthcare NHS Trust-BRC Funding (RDA02), the Novo Nordisk Young Investigator Award (NNF20OC0059309) and the NIHR Health Protection Research Unit in Modelling Methodology. J.M. Brauner was supported by the EPSRC Centre for Doctoral Training in Autonomous Intelligent Machines and Systems (EP/S024050/1) and by Cancer Research UK. J.S. Brownstein and B. Rader acknowledge funding from the Centers for Disease Control and Prevention [75D30120C07727], Flu Lab, and Ending Pandemics. S. Bhatt thanks Microsoft AI for Health and Amazon AWS for computational credit.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data can be downloaded with the instructions on the Github repo: https://github.com/g-leech/masks_v_mandates